Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,702.00
Ask: 1,703.00
Change: -20.00 (-1.16%)
Spread: 1.00 (0.059%)
Open: 1,729.00
High: 1,729.00
Low: 1,699.00
Prev. Close: 1,725.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 Nov 2013 07:00

RNS Number : 3395T
Smiths Group PLC
19 November 2013
 

 

News Release

London, 19 November 2013

For immediate release

 

 

SMITHS GROUP PLC INTERIM MANAGEMENT STATEMENT

 

Smiths Group Chairman Donald Brydon will make the following Interim Management Statement at the Company's Annual General Meeting in London today.

 

In the three months to 2 November 2013, overall trading at Smiths Group has been in line with expectations. Revenue and headline operating profit have both grown on an underlying and reported basis. Headline operating profit improvements in Detection, John Crane and Flex-Tek more than offset some weakness in Medical and Interconnect. Expectations for the year remain broadly in line with the outlook given at the full year results, although foreign exchange translation is expected to be a headwind at current rates and sales to government-funded customers remain a risk.

 

John Crane delivered modest headline operating profit growth in the first quarter as a result of productivity gains and favourable mix. Revenue was at a similar level to last year with continued growth in aftermarket revenues offsetting weaker sales to first fit OEM customers, reflecting the phasing of certain projects. The order book is ahead of last year with a positive book-to-bill ratio. As a result, John Crane is expected to grow in line with the outlook given at the full year results in September.

 

Smiths Medical saw underlying revenue decline as improved hardware sales were more than offset by a weakness in demand for single-use consumables. As expected, headline operating profit in the first quarter was held back by the impact of the US medical device tax and continued tough trading in developed markets. The full year performance is expected to be below the prior year for the same reasons.

 

Smiths Detection delivered strong underlying revenue and headline operating profit in the first quarter against a weak comparator period. We continue to pursue operational improvements and manufacturing efficiencies. The order book for the full year remains slightly below the equivalent point last year. As a result, we remain cautious about the revenue outlook, but expect productivity initiatives to benefit margins.

 

Smiths Interconnect experienced declines in underlying revenue and headline operating profit against a strong comparator period. Growth in Power was offset by lower revenues in Microwave and Connectors caused by a slowdown in demand from defence customers and on-going weakness in Europe, despite increased sales in the telecommunications market. Looking to the full year, improved trading in some commercial end markets is likely to offset weaker demand in defence, resulting in relatively modest growth overall, with a bias to the second half.

 

Flex-Tek has made good progress growing underlying revenue through a strong performance in US residential construction. Headline operating profit and margins improved as a result of the higher volumes. Despite a demanding comparator period, the outlook for the full year remains positive driven by the aerospace order book and US housing.

 

At 2 November, net debt was £740m, slightly reduced from the £744m at 31 July 2013.

 

ENDS

This press release contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of the press release and the Company undertakes no obligation to update these forward-looking statements. Nothing in this press release should be construed as a profit forecast.

 

 

Investor Relations

Peter Durman: +44 (0)20 7808 5535

 

Media Relations

Colin McSeveny: +44 (0)20 7808 5534

Anthony Cardew - Cardew Group: +44 (0)20 7930 0777

 

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFEDLELTLIV
Date   Source Headline
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSTransaction in Own Shares
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:00 pmRNSDirector Responsibilities
1st Feb 20221:30 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSTransaction in Own Shares
31st Jan 202212:00 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
27th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20227:00 amRNSTransaction in Own Shares
24th Jan 20227:00 amRNSTransaction in Own Shares
21st Jan 20228:00 amRNSAdditional Listing
21st Jan 20227:00 amRNSTransaction in Own Shares
20th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
18th Jan 20227:00 amRNSTransaction in Own Shares
17th Jan 20227:00 amRNSTransaction in Own Shares
14th Jan 20227:00 amRNSTransaction in Own Shares
13th Jan 202210:10 amRNSNotice of Optional Redemption
13th Jan 20227:00 amRNSTransaction in Own Shares
12th Jan 20227:00 amRNSTransaction in Own Shares
11th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 20227:00 amRNSTransaction in Own Shares
7th Jan 20227:15 amRNSTransaction in Own Shares
7th Jan 20227:00 amRNSCompletion of Smiths Medical sale
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 20229:30 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 20217:00 amRNSTransaction in Own Shares
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20217:00 amRNSTransaction in Own Shares
22nd Dec 20217:00 amRNSTransaction in Own Shares
21st Dec 20217:00 amRNSTransaction in Own Shares
20th Dec 20217:00 amRNSTransaction in Own Shares
17th Dec 20217:00 amRNSTransaction in Own Shares
16th Dec 20213:09 pmRNSHolding(s) in Company
16th Dec 20217:00 amRNSTransaction in Own Shares
15th Dec 20217:00 amRNSTransaction in Own Shares
14th Dec 20217:00 amRNSTransaction in Own Shares
13th Dec 20217:00 amRNSTransaction in Own Shares
10th Dec 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.